EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITY.
about
The Receptor for Advanced Glycation Endproducts Does Not Contribute to Pathology in a Mouse Mesenteric Ischemia/Reperfusion-Induced Injury Model.Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist.Free Total Rhubarb Anthraquinones Protect Intestinal Injury via Regulation of the Intestinal Immune Response in a Rat Model of Severe Acute Pancreatitis.
P2860
EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITY.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
EPHA4-FC TREATMENT REDUCES ISC ...... IBITING VASCULAR PERMEABILITY.
@en
type
label
EPHA4-FC TREATMENT REDUCES ISC ...... IBITING VASCULAR PERMEABILITY.
@en
prefLabel
EPHA4-FC TREATMENT REDUCES ISC ...... IBITING VASCULAR PERMEABILITY.
@en
P2093
P50
P1433
P1476
EPHA4-FC TREATMENT REDUCES ISC ...... IBITING VASCULAR PERMEABILITY.
@en
P2093
Andrew W Boyd
Angela Jeanes
Michael J Ting
Mike C-L Wu
Nathan T Bain
Stephen M Taylor
P304
P356
10.1097/SHK.0000000000000494
P577
2016-02-01T00:00:00Z